Taxilin Alpha Regulates DNA-Mediated and Interferon-Dependent Innate Immunity
Taxilin Alpha Regulates DNA-Mediated and Interferon-Dependent Innate Immunity
批准号:
9303580
负责人:
Shitao Li
金额:
$43.18万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-02-06 至 2020-01-31
关键词:
Animal ModelAutoimmune DiseasesBindingDNADNA Virus InfectionsDNA VirusesDataDevelopmentDimerizationEndoplasmic ReticulumEnvironmentGenesHealth SciencesHost DefenseImmune responseImmune signalingImmunityIn VitroInterferon ActivationInterferon Type IInterferonsInvestigationKnockout MiceLinkLiteratureMediatingNatural ImmunityOklahomaPathway interactionsPlayPolyubiquitinProductionProteomicsRecruitment ActivityResearchRoleScienceSignal PathwaySignaling MoleculeSpecificitySystemic Lupus ErythematosusTANK-binding kinase 1Transgenic MiceTreatment EfficacyUniversitiesVirus Diseasesbasecareer preparationdimergraduate studentimprovedin vivonovel therapeuticspreventprotein complexresponseundergraduate student
中文摘要
项目总结
虽然外源DNA介导的免疫应答有助于宿主防御,但过量的宿主细胞质
由于干扰素的过度生产,DNA可能会导致自身免疫性疾病。紫杉素α(TXLNA)已被
隐含在胞浆DNA引起的自身免疫性疾病中。然而,TXLNA在DNA介导的先天性中的作用
豁免权是未知的。因此,迫切需要阐明TXLNA如何调节DNA诱导的机制
先天免疫信号。这一应用提出了一种假设,即TXLNA是一种新的信号分子
DNA介导的、干扰素依赖的先天免疫。目标1将建立TXLNA作为TBK1的调节器
DNA介导的体内和体外天然免疫。TXLNA缺乏将建立要求和
Tbk1介导的干扰素激活对DNA反应的特异性。Aim 2将研究这些机制
通过TXLNA调节DNA介导的先天信号通路中的TBK1活性。我们将研究几个
TXLNA介导的TBK1激活和募集到刺痛信号体的假说。机械论
这项建议所衍生的概念,将促进我们目前对
DNA介导的先天免疫。该项目还将为研究生和本科生提供
为进入生物医学科学事业做准备的重大独立研究的机会。
英文摘要
Project summary
While exogenous DNA-mediated immune response contributes to host defense, excessive host cytoplasmic
DNA can result in autoimmune diseases due to interferon overproduction. Taxilin alpha (TXLNA) has been
implied in autoimmune disease caused by cytosolic DNA. However, the role of TXLNA in DNA-mediated innate
immunity is unknown. Thus, it is pressing to elucidate the mechanisms of how TXLNA regulates DNA-induced
innate immune signaling. This application proposes a hypothesis that TXLNA is a new signaling molecule in
DNA-mediated, interferon-dependent innate immunity. Aim 1 will establish TXLNA as a TBK1 regulator in
DNA-mediated innate immunity in vitro and in vivo. TXLNA deficiency will establish the requirement and
specificity in TBK1-mediated interferon activation in response to DNA. Aim 2 will investigate the mechanisms
by which TXLNA regulates TBK1 activity in DNA-mediated innate signaling pathway. We will examine several
hypotheses of TXLNA-mediated TBK1 activation and recruitment to STING signalosome. The mechanistic
concepts derived from this proposal will advance our current understanding of the regulatory mechanisms in
DNA-mediated innate immunity. This project will also provide graduate and undergraduate students with
opportunities for significant independent research in preparation for careers in biomedical science.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of OCIAD1 in RIG-I-mediated STAT1 signaling pathway
-
批准号:10410142
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2022
-
负责人:Shitao Li
-
依托单位:
Role of OCIAD1 in RIG-I-mediated STAT1 signaling pathway
-
批准号:10554293
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2022
-
负责人:Shitao Li
-
依托单位:
Phosphorylation mimetic motif of cryptochrome proteins blocks IRF3 activation
-
批准号:10583785
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2022
-
负责人:Shitao Li
-
依托单位:
K63-linked ubiquitination regulates cGAS activation upon DNA damage
-
批准号:10348290
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2021
-
负责人:Shitao Li
-
依托单位:
K63-linked ubiquitination regulates cGAS activation upon DNA damage
-
批准号:10495239
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2021
-
负责人:Shitao Li
-
依托单位:
Role of FIP200 in RIG-I-mediated innate immunity
-
批准号:10059138
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2018
-
负责人:Shitao Li
-
依托单位:
Role of FIP200 in RIG-I-mediated innate immunity
-
批准号:10295767
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2018
-
负责人:Shitao Li
-
依托单位:
Regulation of cGAS-Mediated Cytosolic DNA Sensing Pathway
-
批准号:10054489
-
项目类别:
-
资助金额:$10.47万
-
财政年份:2018
-
负责人:Shitao Li
-
依托单位:
Role of FIP200 in RIG-I-mediated innate immunity
-
批准号:10507761
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2018
-
负责人:Shitao Li
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: